SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VARANI, Katia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 39.247
AS - Asia 19.133
EU - Europa 12.660
SA - Sud America 3.237
AF - Africa 285
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 26
AN - Antartide 1
Totale 74.616
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 38.527
SG - Singapore 7.257
CN - Cina 5.986
DE - Germania 2.912
BR - Brasile 2.726
UA - Ucraina 2.367
IT - Italia 2.012
TR - Turchia 1.859
HK - Hong Kong 1.850
GB - Regno Unito 1.333
VN - Vietnam 1.065
FI - Finlandia 874
SE - Svezia 826
RU - Federazione Russa 718
PL - Polonia 484
FR - Francia 366
CA - Canada 346
MX - Messico 309
IN - India 211
AR - Argentina 204
ID - Indonesia 197
NL - Olanda 165
JP - Giappone 154
ZA - Sudafrica 140
BD - Bangladesh 128
BE - Belgio 122
ES - Italia 108
EC - Ecuador 90
IQ - Iraq 80
LT - Lituania 80
CZ - Repubblica Ceca 66
AT - Austria 65
CO - Colombia 52
VE - Venezuela 43
UZ - Uzbekistan 42
CL - Cile 39
MA - Marocco 35
PK - Pakistan 34
PY - Paraguay 34
AE - Emirati Arabi Uniti 33
SA - Arabia Saudita 29
KE - Kenya 25
CH - Svizzera 24
IR - Iran 24
JO - Giordania 23
TN - Tunisia 23
IL - Israele 22
KR - Corea 21
AU - Australia 19
UY - Uruguay 19
EU - Europa 18
IE - Irlanda 18
PE - Perù 18
DZ - Algeria 16
RO - Romania 15
EG - Egitto 14
AL - Albania 13
MY - Malesia 12
PT - Portogallo 12
NP - Nepal 11
LV - Lettonia 10
BG - Bulgaria 9
BO - Bolivia 9
DO - Repubblica Dominicana 9
NO - Norvegia 9
TT - Trinidad e Tobago 9
BH - Bahrain 8
HN - Honduras 8
JM - Giamaica 8
TW - Taiwan 8
BA - Bosnia-Erzegovina 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LB - Libano 7
OM - Oman 7
SY - Repubblica araba siriana 7
AM - Armenia 6
CG - Congo 6
CI - Costa d'Avorio 6
CR - Costa Rica 6
MD - Moldavia 6
SN - Senegal 6
AZ - Azerbaigian 5
HR - Croazia 5
HU - Ungheria 5
MK - Macedonia 5
NZ - Nuova Zelanda 5
PH - Filippine 5
PS - Palestinian Territory 5
XK - ???statistics.table.value.countryCode.XK??? 5
BY - Bielorussia 4
GE - Georgia 4
GR - Grecia 4
GT - Guatemala 4
NI - Nicaragua 4
PA - Panama 4
RS - Serbia 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BN - Brunei Darussalam 3
Totale 74.558
Salva come PNG Salva come JPEG
Città #
Singapore 4.153
Woodbridge 3.958
Ashburn 3.569
Fairfield 3.395
Jacksonville 2.606
Chandler 2.499
Houston 2.431
Ann Arbor 2.135
Beijing 1.905
Hong Kong 1.844
Santa Clara 1.807
Dallas 1.451
Wilmington 1.425
Seattle 1.352
Cambridge 1.109
Izmir 896
Nanjing 784
Los Angeles 671
Princeton 585
Munich 526
Ferrara 510
Boardman 475
Warsaw 449
New York 374
Ho Chi Minh City 343
Milan 336
Shanghai 314
San Diego 303
São Paulo 264
Nanchang 251
Shenyang 236
Mexico City 208
Hanoi 207
Turku 188
Tianjin 185
Helsinki 183
Dearborn 179
Hefei 173
London 169
Bremen 167
Changsha 157
Falkenstein 152
Hebei 148
Addison 140
Buffalo 140
Jiaxing 138
Jakarta 137
Tokyo 134
Chicago 132
The Dalles 130
Frankfurt am Main 121
Brussels 118
Montreal 115
Brooklyn 111
San Mateo 99
Moscow 95
Orem 94
Jinan 93
Denver 92
Zhengzhou 91
Falls Church 90
Toronto 90
San Francisco 86
Norwalk 84
Kunming 82
Stockholm 82
Dong Ket 81
Chennai 80
Rio de Janeiro 78
Johannesburg 75
Atlanta 74
Mountain View 70
Boston 69
Phoenix 69
Guangzhou 67
Poplar 64
Bologna 62
Manchester 62
Auburn Hills 59
Council Bluffs 59
Düsseldorf 58
Orange 58
Belo Horizonte 56
Ankara 55
Ningbo 55
Haiphong 54
Columbus 50
Philadelphia 50
Amsterdam 49
Redwood City 49
Rome 48
Washington 45
Porto Alegre 44
Brasília 43
Augusta 41
Des Moines 39
Nuremberg 38
Brno 37
Curitiba 37
Hangzhou 37
Totale 49.478
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 1.171
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 345
Pharmacology of Adenosine Receptors: The State of the Art 295
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 289
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 265
A glance at adenosine receptors: Novel target for antitumor therapy 262
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 254
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 243
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 238
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 236
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 236
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 235
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 230
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 229
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 227
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 226
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 221
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 220
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 219
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 218
Adenosine receptors and human melanoma 216
The A3 adenosine receptor: history and perspectives 216
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 214
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 212
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 211
Recettori e trasduzione del segnale 211
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 211
Recettori e trasduzione del segnale 210
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 210
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 209
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 209
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 207
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 207
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 206
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 204
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 200
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 200
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 200
Adenosine receptor targeting in health and disease 199
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 199
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 197
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 196
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 196
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 196
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 195
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 195
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 195
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 195
Comparison of prazosin, terazosin and tamsulosin: Functional and binding studies in isolated prostatic and vascular human tissues 193
Adenosine signaling contributes to ethanol-induced fatty liver in mice 191
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 191
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 190
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 190
Ala scan analogues of HOE 140. Synthesis and biological activities 189
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 189
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 189
Current status of A1 adenosine receptor allosteric enhancers 188
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 187
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 185
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 185
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 184
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 184
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 183
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 183
van't Hoff Based Thermodynamics 183
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 181
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 181
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 180
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 180
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 180
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 179
Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists 179
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 179
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 179
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brain 178
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 178
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 178
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 178
Pathological overproduction: the bad side of adenosine 178
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 177
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 177
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 177
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 177
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 177
4-Amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies 176
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 176
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 176
An evaluation of fMLP pocket dimensions and features using formyltetrapeptides 176
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 175
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 175
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 175
Electrophysiological basis for the enhanced cardiac arrhythmogenic effect of isoprenaline in aged spontaneously hypertensive rats 174
5-heteroarylcarbamoylamino-pyrazolo-triazolo pyrimidines as hA3 adenosine receptor antagonists. 174
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 174
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 174
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 174
7-substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A(2A) adenosine receptor antagonists: A study on the importance of modifications at the side chain on the activity and solubility 174
Binding thermodynamics at A1 and A2A adenosine receptors 173
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 172
A3 adenosine receptors are overexpressed in pleura from patients with mesothelioma and reduce malignant mesothelioma cell growth 172
Totale 20.942
Salva come PNG Salva come JPEG
Categoria #
all - tutte 340.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.582
Totale 348.489
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.224 0 0 0 0 0 711 276 826 165 951 888 407
2021/20225.145 126 552 340 225 245 210 232 269 193 432 731 1.590
2022/20235.734 592 432 176 795 954 821 269 458 700 46 296 195
2023/20242.851 289 377 142 83 316 343 136 209 57 72 77 750
2024/202512.275 311 354 946 618 1.431 1.133 460 739 1.729 1.390 1.711 1.453
2025/202618.682 3.432 1.629 3.585 4.462 4.967 607 0 0 0 0 0 0
Totale 75.330